Academic article

• U Abilgaard; F Brosstad; S Evensen et al. (1997). Vurdering av trombosetendens før forskrivning av p-piller. (external link)
• Helga Salvesen; Lars A. Akslen; Torbjørn Iversen et al. (1997). Recurrent endometrial carcinoma and the value of routine follow-up. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1997). Prognostisk betydning av tumorbiologiske markører ved kreft i livmorslimhinnen. (external link)
• Mette Haase Moen; Stein Tore Nilsen; Ole-Erik Iversen (2005). A significant change in Norwegian gynecologists attitude to hormone replacement therapy is observed after the results of the Women's health initiative study. (external link)
• Anna R. Giuliano; Elmar A. Joura; Suzanne M. Garland et al. (2019). Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. (external link)
• Luisa L Villa; G Perez; S Kjaer et al. (2007). Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. (external link)
• S Majewski; FX Bosch; J Dillner et al. (2009). The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24. (external link)
• Susanne Krüger Kjær; Kristján Sigurdsson; Ole-Erik Iversen et al. (2009). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. (external link)
• Susanne Albrechtsen; Svein Rasmussen; Steinar Østerbø Thoresen et al. (2005). Har conisering betydning for svangerskapsutfall?. (external link)
• Cosette M. Wheeler; Susanne Krüger Kjær; Kristján Sigurdsson et al. (2009). The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years. (external link)
• Nora Johansen; Astrid Helene Liavaag; Ole-Erik Iversen et al. (2017). Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostic impact of morphometric nuclear grade of endometrial carcinoma. (external link)
• Ole-Erik Iversen (2004). Tredjegenerasjons p-piller - hvor stor er risikoen for venøs tromboemboli?. (external link)
• MH Moen; Stein Tore Nilsen; Ole-Erik Iversen (2005). A significant change in Norwegian gynecologist´s attitude to hormone therapy is observed after the results of the Women´s Health Initiative Study. (external link)
• Henry Burger; David Archer; David Barlow et al. (2004). Practical recommendations for hormone replacement therapy in the peri- and postmenopause. (external link)
• Lars Holmberg; Ole-Erik Iversen; Carl Magnus Rudenstam et al. (2008). Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. (external link)
• Halvor Næss; Annette Fromm; Ole-Erik Iversen et al. (2011). Decline of arterial cerebral infarction among young women: the Bergen Stroke Study. (external link)
• Robert L. Reid; Carolyn Westhoff; Diana Mansour et al. (2010). Oral Contraceptives and Venous Thromboembolism Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009. (external link)
• T Fredriksen; MH Moen; Stein Tore Nilsen et al. (1997). Norske gynekologers innstilling til hormonell substitusjon. (external link)
• Elisabeth Wik; Jone Trovik; Ole-Erik Iversen et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (external link)
• Alain Luxembourg; Darron Brown; Celine Bouchard et al. (2015). Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. (external link)
• Edson D. Moreira; Stan L. Block; Daron Ferris et al. (2016). Safety profile of the 9-valent HPV vaccine: A combined analysis of 7 phase III clinical trials. (external link)
• J Cohen; B Hedon; R Kempers et al. (1999). Consensus conference statement on combination oral contraceptives and cardiovascular disease. (external link)
• Joakim Dillner; Susanne Krüger Kjær; Cosette M. Wheeler et al. (2010). Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. (external link)
• Peter Hillemanns; Mark H. Einstein; Ole-Erik Iversen (2015). Topical hexaminolevulinate photodynamic therapy for the treatment of persistent human papilloma virus infections and cervical intraepithelial neoplasia. (external link)
• Ole-Erik Iversen; Per Bergsjø (1998). Bør antiprogesteron tas i bruk i Norge?. (external link)
• Mette Løkeland; Tone Bjørge; Ole-Erik Iversen et al. (2016). Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. (external link)
• Lars Holmberg; Harald Anderson; Ole-Erik Iversen (2004). HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped. (external link)
• Nubia Muñoz; Susanne Krüger Kjær; Kristján Sigurdsson et al. (2010). Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on all HPV-associated genital diseases in young women. (external link)
• Susanne Albrechtsen; Svein Arvid Rasmussen; Steinar Thoresen et al. (2008). Pregnancy outcome in women before and after cervical conisation: population based cohort study. (external link)
• Edson Duarte Moreira; Anna R. Giuliano; Jan N.J.M. de Hoon et al. (2018). Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age. (external link)
• Trond Markestad; P Lossius; Helga Maartmann-Moe et al. (1997). Cell division in placentas of appropriate and small-for-gestational-age infants. A flow cytometry study. (external link)
• Helga Salvesen; Lars A. Akslen; Torbjørn Iversen et al. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. (external link)
• Daron Ferris; Rudiwilai Samakoses; Stan L. Block et al. (2014). Long-term study of a quadrivalent human papillomavirus vaccine. (external link)
• Kevin A. Ault; Elmar A. Joura; Susanne Krüger Kjær et al. (2011). Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. (external link)
• Ole-Erik Iversen (2000). The effects of progestogens on the endometrium. (external link)
• ND Macdonald; Helga Salvesen; A Ryan et al. (2004). Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. (external link)
• Ole-Erik Iversen (2001). Mifepriston - et kontroversielt legemiddel med stort potensiale. (external link)
• Stein Tore Nilsen; Anette Pedersen; Mette Haase Moen et al. (2001). Knowledge, attitudes and management strategies in Scandinavia concerning Hormone replacement therapy. (external link)
• E. Bjørnestad; Ole-Erik Iversen; J. Raeder (2009). Wrapping of the legs versus phenylephrine for reducing hypotension in parturients having epidural anaesthesia for caesarean section: a prospective, randomized and double-blind study. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1999). Prognostic significance of tumor angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (external link)
• Lone K. Petersen; Jaime Alberto Restrepo; Edson Duarte Moreira et al. (2017). Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - a combined analysis of five phase III clinical trials. (external link)
• Xavier Castellsagué; Kevin A. Ault; F. Xavier Bosch et al. (2016). Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. (external link)
• Stein Tore Nilsen; Stein Tore Nilsen; Anette Pedersen et al. (2001). Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement thereapy. A comparison between gynecologists in Denmark, Norway and Sweden. (external link)
• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1998). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship due to biology or behaviour?. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Identification of high-risk patients by assessment of nuclear Ki67 expression in a prosepective study of endometrial carcinoma patients. (external link)
• Mette Løkeland; Ole-Erik Iversen; Anders Engeland et al. (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. (external link)
• Luisa L Villa; Gonzalo Perez; Susanne Krüger Kjær et al. (2007). Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. (external link)
• Mette Løkeland; Ole-Erik Iversen; Gunhild Svanes Dahle et al. (2010). Medical Abortion at 63 to 90 Days of Gestation. (external link)
• Sven-Eric Olsson; Susanne K Kjaer; Kristján Sigurdsson et al. (2009). Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. (external link)
• Ole-Erik Iversen; Per Bergsjø (1998). Bør antiprogesteron tas i bruk ved svangerskapsavbrudd?. (external link)
• Jason R. Navari; Philip Y. Roland; Pacita Keh et al. (2000). Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene. (external link)
• Ole-Erik Iversen (2001). Gestagentillegg ved østrogenbehandling i klimakteriet. (external link)
• Kari Fismen; Inger Johanne Osland; Eirik Fismen et al. (2000). Rehabilitering av kvinner med brystkreft. (external link)
• Svein Magne Skulstad; Svein Rasmussen; Ole-Erik Iversen et al. (2001). The development of high venous velocity of the fetal umbilical ring during gestational weeks 11–19. (external link)
• Mari Nygård; Birgit Øvstebø Engesæter; Philip E. Castle et al. (2022). Randomized implementation of a primary human papillomavirus testing-based cervical cancer screening protocol for women 34 to 69 years in Norway. (external link)
• Helga Salvesen; Ole-Erik Iversen; Claes Tropé (2005). Molekylærdiagnostiske metoder innen gynekologisk kreft. (external link)
• Olav Karsten Vintermyr; Ole-Erik Iversen; Steinar Østerbø Thoresen et al. (2014). Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. (external link)
• Anette Pedersen; Ole-Erik Iversen; Ellen Løkkegaard et al. (2007). Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostic impact of morphometric nuclear grade in endometrial carcinoma. (external link)
• M.H. Moen; T. Fredriksen; Stein Tore Nilsen et al. (1998). Norske gynekologers holdning til østrogen substitusjon. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1999). Prognostic significance of angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (external link)
• Peter Hillemanns; Francisco Garcia; Karl Ulrich Petry et al. (2015). A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2. (external link)
• Stein Tore Nilsen; T. Fredriksen; Ole-Erik Iversen et al. (1998). Norske gynekologers holdning til og praksis ved hormonsubstitusjonsbehandling i klimakteriet. (external link)
• Grete Alræk Iversen; Mette Løkeland; Anneli Kathrine Fjereide et al. (2012). Er det mulig å få pålitelig kunnskap om psykiske senvirkninger etter provosert abort?. (external link)
• Daron G. Ferris; Rudiwilai Samakoses; Stanley L Block et al. (2017). 4-valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents after 10 years. (external link)
• Elmar A. Joura; Anna R. Giuliano; Ole-Erik Iversen et al. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. (external link)
• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1998). Poorer survival of nulliparous women with endometrial carcinoma. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. (external link)
• Elmar A. Joura; Susanne Krüger Kjær; Cosette M. Wheeler et al. (2008). HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. (external link)
• Bente Træen; Ole-Erik Iversen; Nina Fjellvang (2001). Beliefs about the use of oral contraception among women in Oslo, Norway. (external link)
• Kjell Å Salvesen; Ole-Erik Iversen; Mathias Onsrud et al. (2006). NorChip saken - nok en gang. (external link)
• Trond Markestad; P. Lossius; H. Maartmann-Moe et al. (1997). Cell division in placentas of appropriate and small for gestational age infants. (external link)
• L. L. Villa; R.L.R. Costa; C.A. Petta et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. (external link)
• Stein Tore Nilsen; Ole-Erik Iversen (1997). Svangerskapsavbrudd ved gruppe 1 sykehus i 1996. (external link)
• J Trovik; D. Øgreid; Jørn Schneede et al. (1997). Tromboembolisk sykdom i graviditet og barseltid, underliggende trombofili?. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (external link)
• Ole-Erik Iversen; Maria Jose Miranda; Angels Ulied et al. (2016). Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. (external link)
• Elmar A. Joura; Kevin A. Ault; F. Xavier Bosch et al. (2014). Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. (external link)
• Helga B. Salvesen; Nicola MacDonald; Andy Ryan et al. (2000). Methylation of hMLH1 in a population-based series of endometrial carcinoma. (external link)
• Line Bjørge; Synnøve Lian Johnsen; Grete Midbøe et al. (2001). Early pregnancy termination with mifepristone and misiprostol in Norway. (external link)
• Line Bjørge; Ole-Erik Iversen (2001). Mifepristone (RU 486) - et kontroversielt legemiddel med stort potensiale. (external link)
• Sven-Eric Olsson; Luisa L Villa; Ronaldo L.R. Costa et al. (2007). Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. (external link)
• Aase Serine Devold Pay; Runa Sigrid Aabø; Inger Økland et al. (2018). Medikamentell abort hos avtalespesialist. (external link)
• Anne Tandberg; Susanna Albrechtsen; Ole-Erik Iversen (1999). Retained placenta: incidence and clinical significance. (external link)
• Trond Markestad; P. Lossius; H. Maartmann-Moe et al. (1997). Cell division in placentas of appropriate and small for gestational age infants. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (external link)
• Warner K. Huh; Elmar A. Joura; Anna R. Giuliano et al. (2017). Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16?26 years: a randomised, double-blind trial. (external link)
• Nicola MacDonald; Helga B. Salvesen; Andy Ryan et al. (2000). Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. (external link)
• Helga Refsum; Anne W. Grindflek; Per Magne Ueland et al. (2004). Screening for serum total homocysteine in newborn children. (external link)
• Darron R. Brown; Susanne Krüger Kjær; Kristján Sigurdsson et al. (2009). The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years. (external link)
• Olav Karsten Vintermyr; Marie Songstad Andersland; Tone Bjørge et al. (2018). Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears. (external link)
• Line Bjørge; Jaakku Hakulinen; Olav Karsten Vintermyr et al. (2005). Ascitic complement system in ovarian cancer. (external link)

Radio or TV participation

• Ole-Erik Iversen (2005). Globale aspekter ved lovende kreftvaksine. (external link)
• Ole-Erik Iversen (1997). "Er Marvelon farligere enn andre p-piller?". (external link)
• Ole-Erik Iversen (1997). Angrepillen og aborter. (external link)
• Ole-Erik Iversen (2005). Virkemidler i abortdebatten. (external link)
• Ole-Erik Iversen (1997). P-pillefrykt og aborttall. "Marvelonsaken". (external link)
• Ole-Erik Iversen (1997). Bør abortpillen brukes i Norge? Debatt. (external link)
• Ole-Erik Iversen (1997). Populærvitenskapelig om kreft "Gjest i studio". (external link)
• Ole-Erik Iversen (2005). Debatt om billige p-piller til tenåringer. (external link)
• Ole-Erik Iversen (1997). Skal vi ha reklame for ginseng på sykehus? Debatt. (external link)

Conference lecture

• Ole-Erik Iversen (2003). Postoperativ kjemoterapi ved ovarialcancer. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Ole-Erik Iversen (2000). HTR og mammacancer, HABITS studien. (external link)
• Ole-Erik Iversen (2000). Cancer mammae og HRT. (external link)
• Ole-Erik Iversen (2003). Østrogenbehandling. Er det blitt farligere? Hvilke indikasjoner gjelder? Kontraindikasjoner?. (external link)
• Ole-Erik Iversen (2001). Bruk og misbruk av epidemiologiske data ved HRT og cancer mammae. (external link)
• Ole-Erik Iversen (2001). Substitusjonsbehandling i klimakteriet. (external link)
• Ole-Erik Iversen (2001). Corpuscancer. (external link)
• Ole-Erik Iversen (2001). HABITS-studien. Bakgrunn og status. (external link)
• Ole-Erik Iversen (2001). HABITS studien (Hormonal replacement therapy after breast cancer diagnosis - is it safe?) Bakgrunn og status. (external link)
• Ole-Erik Iversen (2001). HRT og cancer mammae. HABITS-studien status 2001. (external link)
• Ole-Erik Iversen (2005). A burden of global proportions. (external link)
• Ole-Erik Iversen (2004). Hormonbehandling etter brystkreft. Status i HABITS studien. (external link)
• Ole-Erik Iversen (2003). Cx cancer: Fra naturlig forløp via terapi, sekundær -, til primærprofylakse. (external link)
• I. B. Engelsen; Susanna Albrechtsen; Ole-Erik Iversen (1997). Peripartum hysterektomi - Insidens og maternell morbiditet. (external link)
• Ole-Erik Iversen (2003). HRT etter cancer mammae - er det trygt?. (external link)
• Ole-Erik Iversen (2003). HPV-vaksine. Kan cervixcancer forebygges?. (external link)
• Ole-Erik Iversen (2003). Sikkerhetsaspekter, brystkreft og andre kreftformer, økning/reduksjon ved HRT. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Anne Tandberg; Ole-Erik Iversen (2000). Surgical evacuation following medically induced second trimester abortion. (external link)
• KH Kalland; Lars A. Akslen; OJ Halvorsen et al. (2003). Global gene expression profiling of human cancers using DNA microarray technology - examples, pitfalls and outlook. (external link)
• Ole-Erik Iversen (2001). Medisinsk abort - hvorfor og hvordan?. (external link)
• Ole-Erik Iversen (2001). Oppdatering prevensjon, p-piller og hormonelle metoder. Abortmetoder. (external link)
• Ole-Erik Iversen (2003). HRT etter HERS og WHI. Veien videre (Jordskjelv eller krusninger??). (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Ole-Erik Iversen (2003). HRT eller WHI??. (external link)
• Ole-Erik Iversen (2003). a)HRT og CVD, b)HRT og cancer. (external link)
• I. B. Engelsen; Susanna Albrechtsen; Ole-Erik Iversen (1997). Peripartum hysterectomy. Incidence and maternal morbidity. (external link)
• Ole-Erik Iversen (2003). HPV-vaksinasjon. Bakgrunn og strategi. (external link)
• Ole-Erik Iversen (2003). P-piller. (external link)
• Anne Tandberg; Ole-Erik Iversen (2000). Surgical evaluation following medically induced second trimester abortion. A Nordic Investigation. (external link)
• Ole-Erik Iversen (2000). HRT before, today and in the future. (external link)
• Ole-Erik Iversen (2000). Hormonsubstitusjon og kreftrisiko. (external link)
• Ole-Erik Iversen (2000). Substitusjonsbehandling i klimakteriet. (external link)
• Mette Haase Moen; Stein Tore Nilsen; Stein Tore Nilsen et al. (2003). A change in attitudes and prescribing practice of hormone replacement therapy among Norwegian gynaecologists during the last 5 years. (external link)
• Ole-Erik Iversen (2004). HRT til kvinner med cancer. (external link)
• Ole-Erik Iversen (2004). Corpuscancer. (external link)
• Ole-Erik Iversen (2004). Breast issues with hormone therapy. (external link)
• Ole-Erik Iversen (2004). HABITS studien. Hvordan forholder vi oss i dag til brystkreftpasienter og risikokvinner mht østrogenbehandling?. (external link)
• Ole-Erik Iversen (2003). Blødningsforstyrrelser. (external link)
• Ole-Erik Iversen (2001). Blødningsforstyrrelser i klimakteriet. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1997). Independent prognostic importance of microvessel density in endometrial carcinoma. [poster]. (external link)
• Ole-Erik Iversen (2003). Corpuscancer. (external link)
• Ole-Erik Iversen (2003). P-piller-trombose. (external link)
• Ole-Erik Iversen (2003). Østrogenbehandling for klimakterielt besvær - er det trygt etter brystkreft?. (external link)
• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2011). MEDICAL ABORTION WITH HOME ADMINISTRATION OF MISOPROSTOL UP TO 63 DAYS GESTATION. (external link)
• K. Gjelland; Ole-Erik Iversen (2000). The endometrium in postmenopausal asymptomatic women. Findings with transvaginal ultrasonography (TVS) and clinical relevance. (external link)
• Ole-Erik Iversen (2000). Corpuscancer. (external link)
• Ole-Erik Iversen (2000). HRT i går, i dag og i morgen. (external link)
• Ole-Erik Iversen (2000). Gynekologiske cancere og HRT. (external link)
• Ole-Erik Iversen (2000). Blødningsforstyrrelser i Klimakteriet. (external link)
• Ole-Erik Iversen (2000). Medisinsk abort - hvorfor og hvordan?. (external link)
• Ole-Erik Iversen (2000). HRT og brystcancer, relasjon til osteporose profylakse, fremtidige perspektiver. (external link)
• Ole-Erik Iversen (2003). HRT eller WHI??. (external link)
• Ole-Erik Iversen (2001). HRT og cancer hos postmenopausale kvinner. En oppdatering. (external link)
• Ole-Erik Iversen (2001). HABITS-studien (Hormonal Replacement Therapy After Breast Cancer diagnosis - is it safe?). Bakgrunn og status. (external link)
• Kjell Løvslett; FE Skjeldestad; B Hagen et al. (1997). Standardisert registrering av behandling av premaligne lidelser i cervix uteri, et prøveprosjekt i Helseregion III og IV. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• E Jellum; Aa Andersen; K Baklien et al. (1997). Use of the Janus serum bank in cancer research. (external link)
• Ole-Erik Iversen (2003). Østrogenbehandling. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Ole-Erik Iversen (2003). SMM rapport ovarialcancer og "HRT etter ca. mammae - er det trygt?". (external link)
• Ole-Erik Iversen (2003). HRT and breast cancer. Hot topics in Gyn/Obst. (external link)
• Ole-Erik Iversen (2003). HRT og cancer. (external link)
• Ole-Erik Iversen (2003). Bruk og misbruk av epidemiologiske data. (external link)
• Ole-Erik Iversen (2000). Østrogenbehandling og kreftrisiko. (external link)
• Ole-Erik Iversen (2004). Hvordan forholder vi oss i dag til brystkreftpasienter og risikokvinner mht østrogenbehandling?. (external link)
• Ole-Erik Iversen; Stein Tore Nilsen (2004). Changes in attitudes and use of hormone replacement therapy among Scandinavian Gynecologists. (external link)
• Ole-Erik Iversen (2003). Hjerte/karsykdom og østrogenbehandling. (external link)
• Ole-Erik Iversen (2004). Human papilloma vaccines. (external link)
• Ole-Erik Iversen (2001). HABITS-studien. Bakgrunn og status. (external link)
• Ole-Erik Iversen (2001). HRT og coloncancer - er der en sammenheng?. (external link)
• Ole-Erik Iversen (2001). HRT cancer. (external link)

Lecture

• Ole-Erik Iversen (1997). Substitusjonsbehandling i klimakteriet. (external link)
• Ole-Erik Iversen (1997). Trombose i graviditet, derliggende trombofili?. (external link)
• Ole-Erik Iversen (1997). Østrogener og mammacancer. (external link)
• Ole-Erik Iversen (1997). Norske gynekologers holdninger til og bruk av østrogensubstitusjon. (external link)
• Ole-Erik Iversen (1997). Østrogensubstitusjon. (external link)
• Ole-Erik Iversen (1997). Blødningsforstyrrelser i klimakteriet. (external link)
• Ole-Erik Iversen (1997). P-piller - nødprevensjon. (external link)
• T Fredriksen; M Moen; Stein Tore Nilsen et al. (1997). Norske gynekologers innstilling til østrogensubstitusjon. (external link)
• Ole-Erik Iversen (1997). Øker p-piller og østrogenbehandling risikoen for kreft?. (external link)
• Ole-Erik Iversen (1997). Gynekologisk cancer hos gravide. (external link)
• Ole-Erik Iversen (1997). P-piller - Levonova og Depo-Provera. (external link)
• Ole-Erik Iversen (2001). P-pille - angrepille - abortpille. Hva er hva - og hvordan brukes de?. (external link)
• Ole-Erik Iversen (1997). Hva vet vi om østrogener og risiko for kreft?. (external link)
• J Trovik; Ole-Erik Iversen (1997). Tromboembolisk sykdom i graviditet og barseltid, underliggende trombofili? [Prisbelønnet som beste innlegg]. (external link)
• J Trovik; Ole-Erik Iversen (1997). Hvordan praktiseres svangerskapskontroll etter conisering i Norge?. (external link)
• Ole-Erik Iversen (1997). Abortpillen, hva er det? Bør den brukes i Norge?. (external link)
• J Trovik; Ole-Erik Iversen (1997). Endring av behandlingsmetode ved cervixdysplasi i Norge i perioden 1979-1995. (external link)
• Ole-Erik Iversen (1997). Arguments pro estrogen therapy for women with breast cancer. (external link)
• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Recurrent endometrial and the value of routine follow up. (external link)
• Ole-Erik Iversen (1997). Østrogener og cancerrisiko. "Habits" studien. (external link)
• Ole-Erik Iversen (1997). P-piller - nødprevensjon. (external link)
• Ole-Erik Iversen (1997). Hormoner og kreft. (external link)
• Ole-Erik Iversen (1997). P-piller - nødprevensjon. (external link)
• Ole-Erik Iversen (1997). [Møteleder]. (external link)
• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (external link)
• Ole-Erik Iversen (1997). Øker p-piller og østrogenbehandling risikoen for kreft?. (external link)
• Ole-Erik Iversen (1997). [Chairman]. (external link)
• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (external link)

Media interview

• Ole-Erik Iversen (2005). Prevensjonsmåter som fjerner mensen. (external link)
• Ole-Erik Iversen (2005). Tar p-piller for å slippe mensen. (external link)
• Sveinung Wergeland Sørbye; Bjørn Westre; Jon Lømo et al. (2010). Vil fjerne test som kan hindre kreft. (external link)
• Ole-Erik Iversen (2005). Frykter dårligere fødetilbud. (external link)
• Ole-Erik Iversen (2005). Vil lage abortregister. (external link)
• Ole-Erik Iversen (2005). Haukelandprofessor leder lovende vaksineprosjekt. (external link)
• Ole-Erik Iversen (2005). Ubegrunnet skepsis mot p-pillen. (external link)
• Ole-Erik Iversen (2005). Gode resultater med kreftvaksine hos barn. (external link)
• Sveinung Wergeland Sørbye; Emily Burger; Maj Liv Eide et al. (2014). Feiltolkninger koster tjue liv i året. (external link)
• Sveinung Wergeland Sørbye; Giske Ursin; Ole-Erik Iversen (2016). Mener piloten på HPV-screening blir umulig å evaluere. (external link)
• Sveinung Wergeland Sørbye; Ivar Sønbø Kristiansen; Giske Ursin et al. (2016). Fortsatt strid om etikken bak HPV-prosjekt. (external link)
• Ole-Erik Iversen (2005). Usaklig abortfilm på internett (L. Nessa). (external link)
• Ole-Erik Iversen (2005). Utvidet tilbud om medisinsk abort ved KK. (external link)
• Ole-Erik Iversen (2005). Verdien av nye nasjonale retningslinjer for ultralydmåling av foster. (external link)
• Ole-Erik Iversen (2005). Stadig flere tar abort med piller. (external link)
• Ole-Erik Iversen (2005). Gynekologer kritiske til HPV testing. (external link)
• Ole-Erik Iversen (2005). Gjennombrudd for kreftvaksine. (external link)
• Sveinung Wergeland Sørbye; Ole-Erik Iversen; Carl Henrik Knutsen (2013). Slik kan sex og kreft henge sammen. (external link)
• Ole-Erik Iversen (2005). Vil lage abortregister. (external link)
• Ole-Erik Iversen (2005). HPV-virus. Kreftviruset "alle har". (external link)
• Ole-Erik Iversen (2005). HPV-test kun ved celleforandringer. (external link)
• Ole-Erik Iversen (2005). Strid om billige p-piller til tenåringer. (external link)
• Ole-Erik Iversen (2005). Moderne prevensjonsmidler. (external link)
• Sveinung Wergeland Sørbye; Ole-Erik Iversen (2013). 600 får årlig kreft av HPV. (external link)

Academic book chapter

• M Onsrud; C Tropé; Ole-Erik Iversen (1997). Ovarialcancer. (external link)
• Ole-Erik Iversen (2003). Cancer mammae: Epidemiologi, effekt av hormonbehandling, behandling av cancer mammae pasienter. (external link)
• Ole-Erik Iversen; O Istre; T Winge (1997). Bleeding disturbance (menometrorrhagia). (external link)
• Ole-Erik Iversen (2003). Østrogensubstitusjon og andre cancerformer. (external link)
• Ole-Erik Iversen (2003). Østrogenbehandling og risiko for endometriecancer. (external link)
• Ole-Erik Iversen; N Sørheim; Torbjørn Iversen et al. (1997). Prekankrøse lidelser i cervix. (external link)
• Ole-Erik Iversen; O Istre; T Winge (1996). Meno-metrorragi. (external link)
• Pål Øian; Ole-Erik Iversen (2003). Metabolske og fysiologiske forskjeller ved bruk av p-piller og postmenopausal hormonsubstitusjon. (external link)
• Ole-Erik Iversen; Torbjørn Iversen; C. Trope et al. (1998). Premaligne og maligne forandringer i cervix i graviditet. (external link)

Letter to the editor

• C Trope; Ole-Erik Iversen (2009). Fra undring til uro – Tidsskriftet, nobelprisen og HPV-vaksinen. (external link)
• Ole-Erik Iversen (2004). En redelig debatt?. (external link)
• Ole-Erik Iversen; Kjell Å Salvesen (2004). Når redaktører krysser klinger. (external link)
• Ole-Erik Iversen (2017). HPV-vaksinen ti år – hva er status?. (external link)
• Ole-Erik Iversen (2001). Progesteron - medisin eller kommers?. (external link)
• Rita Steen; Bjørn Hagen; Bjørn Magnus Hagmar et al. (2008). Hva er optimal alder for start av cervixscreening?. (external link)
• Ole-Erik Iversen (2001). Gestagentillegg. (external link)

Conference abstract

• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2012). Medical abortion at 9-12 weeks. (external link)
• Kathrine Woie; Terje Sordal; Tore Lunde et al. (2012). Hexaminolevulinate photodynamic therapy for treatment of cervical dysplasia. (external link)
• Mette Løkeland; Ole-Erik Iversen; Stein Emil Vollset et al. (2012). Trender i bruken av medikamentell abort i Noreg. (external link)
• Birgitte Nordby; Marthe Rosvoll; Ole-Erik Iversen et al. (2012). HPV-vaksinasjon – er kunnskapsnivået hos norske medisinetstudenter og allmennleger tilstrekkelig høyt?. (external link)
• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2012). Medical abortion with home administration of misoprostol up to 63 days gestation. (external link)

Popular science article

• Ole-Erik Iversen (2000). Feil om abortpillen. (external link)
• Ole-Erik Iversen (1997). "Er hormoner svaret på en problemfri alderdom?". (external link)
• Ole-Erik Iversen (2000). Professor vil gi abortpille til alle abortsøkende. (external link)
• Ole-Erik Iversen; Helga Salvesen; Lars A. Akslen (1998). Prognostisk betydning av tumorbiologiske markører. (external link)
• T Christoffersen; Ole-Erik Iversen; Torbjørn Iversen et al. (2003). Hormonbehandling av kvinner med menopausale symptomer. Nye nasjonale anbefalinger. (external link)
• Ole-Erik Iversen; KÅ Salvesen (2004). Når redaktører krysser klinger. (external link)
• Ole-Erik Iversen (2000). Progesteron - kilden til det gode liv?. (external link)
• Ole-Erik Iversen (2000). Månedlige myter. (external link)
• Ole-Erik Iversen; Grete Midbøe; Synnøve Lian Johnsen et al. (2003). Medikamentell abort ("abortpillen") - de første norske erfaringene. (external link)
• Ole-Erik Iversen (2000). Hvordan virker abortpillen. (external link)
• Ole-Erik Iversen (2000). Angrepillen er ikke en tidlig abortpille. (external link)
• Ole-Erik Iversen (2000). Økt bruk av p-pillen og hormonspiralen. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostisk betydning av tumorbiologiske markører ved livmorkreft. (external link)
• Ole-Erik Iversen (1997). "Ubegrunnet p-pillefrykt". (external link)
• Ole-Erik Iversen (2006). Utelukker tidligere brystkreft østrogenbehandling?. (external link)

Academic literature review

• Mette Haase Moen; Ole-Erik Iversen (2020). Hormonbehandling i klimakteriet Hva er historien, og hvor står vi i dag?. (external link)
• Trond Melbye Michelsen; Ole-Erik Iversen (2011). Masseundersøkelser mot gynekologisk kreft - status og fremtid. (external link)
• Ole-Erik Iversen (2004). HPV test som supplement til cervixcytologi. Trenger vi det?. (external link)
• Lena Dillner; Sonia Pagliusi; Freddie Bray et al. (2008). Strengthening prevention programs to eliminate cervical cancer in the Nordic countries. (external link)

Research report

• Roald Ekanger; Bjørn Hagen; A Himmelmann et al. (2003). Primær behandling av ovarialcancer. (external link)
• Torbjørn Iversen; G Rosvold Berntsen; Åsa Rytter Evensen et al. (2003). Østrogenbehandling for klimakterielle besvær - er det trygt etter brystkreft?. (external link)

Doctoral thesis (PhD)

• Ole-Erik Iversen (1987). Cellular DNA and steroid receptors in endometrial and ovarian carcinomas.: clinical and prognostic importance. (external link)

Media feature article

• Ole-Erik Iversen (1997). Flere utførte aborter i 1996. (external link)
• Ole-Erik Iversen (1997). "Varmebehandling - jo før jo heller". (external link)
• Ole-Erik Iversen (1997). Angrepillen og aborter. (external link)
• Erik Fink Eriksen; Mette Haase Moen; Ole-Erik Iversen (2018). Østrogener i menopausen - på tide å endre anbefalingene?. (external link)
• Ole-Erik Iversen (1997). P-piller beskytter mot kreft. (external link)
• Ole-Erik Iversen (1997). "Østrogen er gunstig for kvinner. Økt brystkreftfare?". (external link)
• Ole-Erik Iversen (1997). "Østrogen mot kreftplager". (external link)
• Ole-Erik Iversen (1999). Endometriecytologi - status 1999. (external link)
• Pål Øian; Emma Grammeltvedt; Ole-Erik Iversen et al. (2021). Etablering av behandlingsmetoder uten kritisk refleksjon. (external link)

Editorial/Leader article

• Ola Dale; Erik Magnus Berntsen; Mette Brekke et al. (2017). Har redaksjonskomiteen fortsatt betydning?. (external link)

Conference poster

• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1997). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship dur to biology or behaviour? [poster]. (external link)
• Stein Tore Nilsen; Stein Tore Nilsen; Mette Haase Moen et al. (2002). Norske gynekologers holdning til og bruk av HRT i 1997 og 2002. (external link)
• Helga B. Salvesen; Nicola MacDonald; Andy Ryan et al. (2000). Methylation of hMLH1 indicate a distinct pathway in endometrial carcinogenesis. (external link)

See a complete overview of publications in Cristin.